Manuscripts Published in 2009


Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen
European Journal of Haematology, February 2009
View Abstract

A Phase I Study of Samarium Lexidronam/Bortezomib Combination Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma
Clinical Cancer Research, February 2009
View Abstract